Trials / Completed
CompletedNCT02469259
The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD
The Effects of Oxytocin on Social Ability, Alcohol Approach Bias, and Startle Hyperreactivity in Veterans With Alcohol Use Disorder and Post Traumatic Stress Disorder
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the effects of oxytocin on alcohol-related behaviors, social abilities, and physiological startle responses in healthy individuals and patients with posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) using a randomized, placebo-controlled, dose-tiered, between-subject study design. Specifically, the investigators will determine if intranasal administration of a single dose of the pro-social neuropeptide oxytocin decreases alcohol-related approach bias and cravings, enhances social abilities, and decreases physiological hyperactivity. The investigators will also determine the optimal dose to achieve these effects and will explore psychosocial predictors of responses to oxytocin. The proposed work has the potential to yield a novel pharmacological treatment for AUD and PTSD, both leading causes of disability in the US Military for which currently available treatments are inadequate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
- First posted
- 2015-06-11
- Last updated
- 2019-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02469259. Inclusion in this directory is not an endorsement.